Enasidenib

CHEMBL3989908 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

473.4 g/mol

LogP

3.5

Phase

4

This oral medication works by blocking a mutated enzyme called IDH2 that drives the growth of certain leukemia cells. It helps abnormal cells mature into normal blood cells instead of continuing to divide uncontrollably.

분자량

473.4000 g/mol

LogP

3.50

TPSA

109.00 Å²

리핀스키 5의 법칙

통과

치료 영역

Pancreatic Cancer Lymphoma Breast Cancer Prostate Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1

InChI

InChI=1S/C19H17F6N7O/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32)

Molecular Formula

C19H17F6N7O

HBD / HBA

3 / 14

회전 가능 결합

6

무거운 원자

33

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

This oral medication works by blocking a mutated enzyme called IDH2 that drives the growth of certain leukemia cells. It helps abnormal cells mature into normal blood cells instead of continuing to divide uncontrollably.

Yes, Enasidenib is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989908. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 89683805. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Enasidenib PillFYI에서

구조

핵심 데이터

분자식: C19H17F6N7O
동의어: 1

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.